When is a chimaera not a chimaera?
-
By
-
Shaun R. McCann
-
August 24, 2022
-
0 min
When Does a Chimaera Cease to Be a Chimaera?
Overview
This article explores the concept of chimaerism in hematopoietic cell transplantation (HCT) and draws parallels with viticulture, particularly the grafting of American rootstock onto European vines to combat phylloxera. It highlights the biological and historical significance of chimaeras and hybrids in medicine and agriculture.
Background
Chimaerism in medicine refers to the presence of two genetically distinct cell populations within an individual, commonly seen after allogeneic hematopoietic cell transplantation (HCT). Radiation chimaeras were first described in mice, where donor hematopoietic cells repopulate the recipient after lethal irradiation. Monitoring chimaeric status post-HCT provides insights into disease progression and graft-versus-host disease (GvHD). In viticulture, grafting American rootstock resistant to phylloxera onto European vines saved the wine industry, creating plants that are chimaeras or hybrids at the cellular or genetic level.
Data Highlights
Key historical and experimental milestones include:
- 1949: Jacobsen et al. demonstrated mouse survival after lethal irradiation with spleen protection.
- Matching donor and recipient cells prolongs survival; mismatches cause secondary disease (Barnes and Loutit).
- 1991: PCR of polymorphic short tandem repeats used to detect donor and recipient hematopoietic tissue.
- Phylloxera devastated European vineyards in the late 19th century; grafting American rootstock provided resistance.
Key Findings
- Radiation chimaeras result from donor hematopoietic cell engraftment after lethal irradiation.
- Chimaeric status monitoring post-HCT can predict relapse and GvHD risk.
- Chimaeras differ from hybrids: chimaeras have genetically distinct cell populations, hybrids have mixed chromosomes in each cell.
- Grafting American rootstock onto European vines creates chimaeric plants resistant to phylloxera.
- Long-term survivors of HCT and grafted vines may appear uniform but are biologically mosaics or hybrids.
Clinical Implications
Understanding chimaerism is crucial for managing patients after allogeneic HCT, as changes in chimaeric status can indicate relapse or complications such as GvHD. Advances in molecular techniques allow precise monitoring of donor and recipient cells. The analogy with viticulture underscores the importance of biological mosaics in both medicine and agriculture, emphasizing the need for tailored approaches to treatment and graft management.
Conclusion
Chimaeras, whether in human hematopoietic systems post-transplant or in grafted vines, represent complex biological mosaics that challenge our perceptions of identity and uniformity. Recognizing and monitoring these mosaics is essential for optimizing clinical outcomes and agricultural resilience.
References
- Jacobsen et al. 1949 -- Mouse survival after lethal irradiation with spleen protection
- Barnes and Loutit -- Importance of donor-recipient matching in transplantation
- McCann 1991 -- PCR detection of donor and recipient hematopoietic tissue
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.